首页> 外文期刊>Clinical and experimental pharmacology & physiology >T-0162, a novel free radical scavenger, reduces myocardial infarct size in rabbits.
【24h】

T-0162, a novel free radical scavenger, reduces myocardial infarct size in rabbits.

机译:T-0162是一种新型的自由基清除剂,可减少兔子的心肌梗塞面积。

获取原文
获取原文并翻译 | 示例
           

摘要

1. We investigated the effects of 1-(3-tert-butyl-2-hydroxy-5-methoxyphenyl)-3-(3-pyridylmethyl)urea hydrochloride (T-0162), a novel low-molecular weight free radical scavenger, on the generation of superoxide anions and hydroxyl radicals in vitro and in vivo and on myocardial infarct (MI) size in an in vivo model of MI in rabbits. 2. It was found that T-0162 scavenged both superoxide anions and hydroxyl radicals in a concentration-dependent manner in vitro. 3. In an in vivo rabbit model with 30 min coronary occlusion and 30min reperfusion, T-0162 scavenged hydroxyl radicals generated in the myocardium during reperfusion. 4. Anaesthetized open-chest Japanese white male rabbits were subjected to 30 min coronary occlusion and 48 h reperfusion. The control group (n = 10) was infused with 10% lecithin solution for 220 min from 10 min before occlusion to 180 min after reperfusion. The pretreatment group (n = 10) was infused with T-0162 dissolved in 10% lecithin solution for 220 min from 10 min before occlusion to 180 min after reperfusion at a rate of 400 microg/kg per min. The post-treatment group (n = 10) was injected with an i.v. bolus of 10 mg/kg T-0162 and was then infused with 400 microg/kg per min T-0162 for 190 min from 10 min before reperfusion to 180 min after reperfusion. After 48 h reperfusion, infarct size was measured histologically and expressed as a percentage of area at risk (AAR). 5. There was no significant difference in haemodynamic parameters among the three groups throughout the experimental period. The per cent infarct size of the AAR in the T-0162 groups (24.8+/-4.3 and 30.5+/-3.9% for pre- and posttreatment groups, respectively) was significantly reduced compared with control (44.7+/-4.1%; P<0.05). There was no significant difference in the AAR among the three groups. 6. In conclusion, T-0162 reduces MI size through the inhibition of reperfusion injury.
机译:1.我们研究了一种新型的低分子量自由基清除剂1-(3-叔丁基-2-羟基-5-甲氧基苯基)-3-(3-吡啶基甲基)脲盐酸盐(T-0162)的作用,体外和体内超氧阴离子和羟基自由基的产生以及在兔体内心肌梗死模型中心肌梗塞(MI)的大小2.发现T-0162在体外以浓度依赖性方式清除了超氧阴离子和羟基自由基。 3.在具有30分钟冠状动脉闭塞和30分钟再灌注的体内兔模型中,T-0162清除了再灌注期间心肌中产生的羟基自由基。 4.将麻醉的开胸日本白雄兔进行30分钟冠状动脉闭塞和48小时再灌注。对照组(n = 10)从阻塞前10分钟到再灌注后180分钟注入10%卵磷脂溶液220分钟。从闭塞前10分钟到再灌注后180分钟,将预处理组(n = 10)注入溶解在10%卵磷脂溶液中的T-0162,持续220分钟,速率为每分钟400微克/千克。后处理组(n = 10)被注射静脉注射。推注10 mg / kg T-0162,然后从再灌注前10分钟到再灌注后180分钟,以每分钟T-0162 400 microg / kg的速度输注190分钟。再灌注48小时后,组织学测量梗死面积,并表示为危险区域(AAR)的百分比。 5.在整个实验期间,三组之间的血流动力学参数没有显着差异。与对照组相比,T-0162组中AAR的梗死面积百分比显着降低(治疗前和治疗后分别为24.8 +/- 4.3和30.5 +/- 3.9%)(44.7 +/- 4.1%;对照组)。 P <0.05)。三组之间的AAR没有显着差异。 6.总之,T-0162通过抑制再灌注损伤来降低MI的大小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号